SCHEMBL6173095

SCHEMBL6173095

COC(=O)/C=C/c1ccc(Cl)cc1NS(=O)(=O)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERBB2 P04626 1/20 0.52
HSP90AA1 P07900 1/20 0.52
HSP90AB1 P08238 1/20 0.52
CCR2 P41597 3/20 0.51
CPT1A P50416 1/20 0.51
CPT1B Q92523 1/20 0.51
KEAP1 Q14145 1/20 0.48
NFE2L2 Q16236 1/20 0.48
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
HSD17B10 Q99714 2/20 0.46
KDM4E B2RXH2 1/20 0.46
PTGDR2 Q9Y5Y4 1/20 0.46
LMNA P02545 2/20 0.46
MAPK1 P28482 1/20 0.46
HTT P42858 1/20 0.46
ALDH1A1 P00352 2/20 0.46
SNCA P37840 1/20 0.46
GAA P10253 1/20 0.43
HPGD P15428 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173102 1.00 ERBB2 (0.52) ERBB2HSP90AA1HSP90AB1CCR2CPT1A
SCHEMBL6170544 0.91 ERBB2 (0.55) ERBB2HSP90AA1HSP90AB1CCR2KEAP1
SCHEMBL6170538 0.91 ERBB2 (0.55) ERBB2HSP90AA1HSP90AB1CCR2KEAP1
SCHEMBL6172083 0.88 ERBB2 (0.57) ERBB2HSP90AA1HSP90AB1CCR2CPT1A
SCHEMBL6172085 0.88 ERBB2 (0.57) ERBB2HSP90AA1HSP90AB1CCR2CPT1A
SCHEMBL6169289 0.87 METAP2 (0.54) CCR2KEAP1NFE2L2MEN1KMT2A
SCHEMBL6169283 0.87 METAP2 (0.54) CCR2KEAP1NFE2L2MEN1KMT2A
SCHEMBL6169783 0.87 HSD17B10 (0.50) ERBB2HSP90AA1HSP90AB1CCR2KEAP1
SCHEMBL6169778 0.87 HSD17B10 (0.50) ERBB2HSP90AA1HSP90AB1CCR2KEAP1
SCHEMBL6170122 0.85 SNCA (0.61) KEAP1NFE2L2MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1045833-B1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER (US) 2005-11-02 EP disclosed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 US disclosed
EP-1065206-B1 Tetrazolylalkyl indole compounds as anti-inflammatory and analgesic agents PFIZER (US) 2002-10-09 EP disclosed
EP-1065204-B1 Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents and as COX-2 inhibitors PFIZER (US) 2002-04-10 EP disclosed
US-6303628-B1 FOR THE TREATMENT OF A MEDICAL CONDITION IN WHICH PROSTAGLANDINS ARE IMPLICATED AS PATHOGENS IN MAMMALS PFIZER INC 2001-10-16 US disclosed
CN-1284064-A 2,3-substituted indole compounds as cox-2 inhibitors PFIZER PHARMA (US) 2001-02-14 CN disclosed
EP-1065204-A1 Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents and as COX-2 inhibitors PFIZER INC. (US) 2001-01-03 EP disclosed
EP-1065206-A1 Tetrazolylalkyl indole compounds as anti-inflammatory and analgesic agents PFIZER INC. (US) 2001-01-03 EP disclosed
EP-1045833-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER INC. (US) 2000-10-25 EP disclosed
WO-1999035130-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER PHARMACEUTICALS INC. (JP) 1999-07-15 WO disclosed